Baricitinib

Administration

  • Type:
  • Dosage Forms:
  • Routes of Administration:
  • Common Trade Names:

Adult Dosing

COVID

  • Duration of therapy is up to 14 days or until hospital discharge
  • Dose dependent on eGFR
    • eGFR ≥60 mL/min/1.73 m2: 4 mg PO once daily
    • eGFR 30 to <60 mL/min/1.73 m2: 2 mg PO once daily
    • eGFR 15 to <30 mL/min/1.73 m2: 1 mg PO once daily
    • eGFR <15 mL/min/1.73 m2: Not recommended.


Pediatric Dosing

Special Populations

Pregnancy Rating

Lactation risk

Renal Dosing

  • Adult:
  • Pediatric:

Hepatic Dosing

  • Adult:
  • Pediatric:

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:

Mechanism of Action

Comments

See Also

References